Peptides and compounds that bind to the IL-1 receptor

Details Peptides and compounds that bind to the IL-1 receptor Peptides and compounds that bind to the IL-1 receptor

1995-06-05

1998-07-28

Tsang, Cecilia J.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

514 12, 530327, 530324, A61K 3808, A61K 3800, C07K 704

Patent

active

057863318

ABSTRACT:
Peptides that bind to the interleukin-1 type I receptor (IL-1RtI) can be used to assay the amount of IL-1R, or an IL-1R agonist or antagonist, in a sample and comprise a sequence of amino acids selected from the group consisting of (1) WXXXGZ.sub.1 W where Z.sub.1 is L, I, A, or Q; (2) XXQZ.sub.5 YZ.sub.6 XX where Z.sub.5 is P or Aze where Aze is azetidine; and Z.sub.6 is S, A, V, or L; and (3) Z.sub.23 NZ.sub.24 SZ.sub.25 Z.sub.26 Z.sub.27 Z.sub.28 Z.sub.29 Z.sub.30 L where Z.sub.23 is D or Y; Z.sub.24 is D or S; Z.sub.25 is S or W; Z.sub.26 is S or Y; Z.sub.27 is D or V; Z.sub.28 is S or W; Z.sub.29 is F or L; and Z.sub.30 is D or L; and where each amino acid is indicated by standard one letter abbreviation; and each X can be selected from any one of the 20 genetically coded L-amino acids or the stereoisomeric D-amino acids. Also provided are peptides which bind to the IL-1RtI, which are 11 to 40 amino acids in length, which comprise the core sequence of amino acids:

REFERENCES:
patent: 4968607 (1990-11-01), Dower et al.
patent: 5039790 (1991-08-01), Adams et al.
patent: 5075222 (1991-12-01), Hannum et al.
patent: 5075288 (1991-12-01), Krueger et al.
patent: 5077219 (1991-12-01), Auron et al.
Estrov. Z., Kurzrock, R., Talpaz, M. Role of Interleukin-1 inhibitory molecules in therapy of acute and chronic myelogenous leuemia. Leukemia and Lymphoma, 10, 407-418, 1993.
Bender et al., "Chapter 20: Pharmacological modulation of interleukin-1," Ann. Rep. Med. Chem. 25:185-191 (1989).
Cwirla et al., "Peptides on phage: A vast library of peptides for identifying ligands," Proc. Natl. Acad. Sci. USA 87:6378-6382 (1990).
Dinarello, "Interleukin-1 and interleukin-1 antagonism," Blood 77(8):1627-1652 (1991).
Dower et al., "The interleukin-1 receptor," Immunol. Today 8(2):46-51 (1987).
Dower et al., "Human cytokine receptors," J. Clin. Immunol. 10(6):289-299 (1990).
Evans et al., "Mapping receptor binding sites in interleukin (IL)-1 receptor antagonist and IL-1.beta. by site-directed mutagenesis," J. Biol. Chem. 270(19):11477-11483 (May 12, 1995).
Fodor et al., "Light-directed, spatially addressable parallel chemical synthesis," Science 251:767-773 (Feb. 15, 1991).
Hannum et al., "Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor," Nature 343:336-340 (1990).
Labriola-Tompkins et al., "Identification of the discontinuous binding site in human interleukin-1.beta. for the type I interleukin 1 receptor," Proc. Natl. Acad. Sci. USA 88:11182-11186 (1991).
Larrick, "Native interleukin 1 inhibitors," Immunol. Today 10(2):61-66 (1989).
McMahan et al., "A novel IL-1 receptor, cloned from B cells by mammalian expression, is expressed in many cell types," EMBO J. 10(10):2821-2832 (1991).
Estrov et al. Role of interleukin-1 inhibitory molecules in therapy of acute and chronic myelogenous leukemia. Leukemia and Lymphoma, 10:407-418, Feb. 1993.

Affiliated with

Also associated with

Rating

Peptides and compounds that bind to the IL-1 receptor does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Peptides and compounds that bind to the IL-1 receptor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Peptides and compounds that bind to the IL-1 receptor will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-23627